vimarsana.com
Home
Live Updates
10x Genomics Advances Leadership and Innovation in Single Ce
10x Genomics Advances Leadership and Innovation in Single Ce
10x Genomics Advances Leadership and Innovation in Single Cell and Spatial Technologies at 2022 AGBT General Meeting
/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced a series of...
Related Keywords
Stockholm ,
Sweden ,
Visium Cytassist ,
Dagmar Walter ,
Michael Schnall Levin ,
Andrew Kohlway ,
Ben Hindson ,
Sarah Taylor ,
Marlon Stoeckius ,
Mike Gibbons ,
Exchange Commission ,
Genomics Inc ,
Securities Exchange ,
Nasdaq ,
Xenium In Situ Analyzer ,
Genome Biology ,
General Meeting ,
Chief Scientific Officer ,
Founding Scientist ,
Chief Technology Officer ,
Isolation Kit ,
Xenium Analyzer ,
Barcode Enabled Antigen Mapping ,
Senior Staff ,
Private Securities Litigation Reform Act ,
Securities Act ,
Securities Exchange Act ,
Financial Condition ,
10x Genomics ,
Nc ,